THENATIONALPULSE (Pulse Wires) - Trump FDA Approves New Cholesterol-Lowering Pill.
The Food and Drug Administration (FDA) has approved a new pill that lowers cholesterol.
The Food and Drug Administration has approved a cholesterol-lowering daily pill called Lipfendra, expanding treatment possibilities beyond statins and injectables. PULSE POINTS WHAT HAPPENED: - DETAIL: On Thursday, the FDA approved Lipfendra , a new cholesterol-lowering pill. Developed by Merck, a German pharmaceutical multinational, Lipfendra belongs to the PCSK9 inhibitor class of medications. PCSK9 is a liver-produced enzyme that regulates blood cholesterol levels. The pill is the first of its kind, as previous PCSK9 inhibitors were only available as injections. The pill is designed to be taken daily. Lipfendra is intended to help patients with hypercholesterolemia, or high LDL, known widely as “bad” cholesterol. According to…Open